Literature DB >> 16952448

Dopamine transporter binding in depressed patients with anhedonia.

Marco Sarchiapone1, Vladimir Carli, Giovanni Camardese, Chiara Cuomo, Daniela Di Giuda, Maria-Lucia Calcagni, C Focacci, Sergio De Risio.   

Abstract

Central dopaminergic dysfunction has been widely proposed as a common neurobiological correlate of the psychopathological expression of anhedonia. The dopamine transporter (DAT) is a predominantly presynaptic receptor that may play a critical role in the pathophysiology of dopaminergic transmission. The aim of our study was to evaluate DAT binding in a population of depressed patients with anhedonia. Single photon emission computed tomography (SPECT) with the radiotracer DATSCAN was used to evaluate DAT binding in 11 depressed patients with anhedonia and 9 healthy comparison subjects. Compared with healthy subjects, patients showed significantly lower DAT binding. No significant correlation was found between DAT binding ratios and scores on administered psychometric tests. These findings suggest an alteration in DAT density in depressed patients with anhedonia that may be a primary susceptibility factor or a secondary phenomenon to reduced dopamine concentration in the synaptic cleft.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952448     DOI: 10.1016/j.pscychresns.2006.03.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  31 in total

Review 1.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

Review 2.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

Review 3.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

4.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

Review 5.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

6.  Suicidality in Bipolar Disorder: The Role of Emotion-Triggered Impulsivity.

Authors:  Sheri L Johnson; Charles S Carver; Jordan A Tharp
Journal:  Suicide Life Threat Behav       Date:  2016-07-13

7.  Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis.

Authors:  Michael T Treadway; Diego A Pizzagalli
Journal:  Biol Mood Anxiety Disord       Date:  2014-03-07

8.  Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction.

Authors:  Huihui Ji; Xuting Xu; Guili Liu; Huifen Liu; Qinwen Wang; Wenwen Shen; Longhui Li; Xiaohu Xie; Haochang Hu; Lei Xu; Wenhua Zhou; Shiwei Duan
Journal:  Exp Ther Med       Date:  2017-12-12       Impact factor: 2.447

9.  Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.

Authors:  Marcelo Q Hoexter; Gustavo Fadel; André C Felício; Mariana B Calzavara; Ilza R Batista; Marilia A Reis; Ming C Shih; Roger K Pitman; Sérgio B Andreoli; Marcelo F Mello; Jair J Mari; Rodrigo A Bressan
Journal:  Psychopharmacology (Berl)       Date:  2012-06-15       Impact factor: 4.530

10.  Dopamine, behavioral economics, and effort.

Authors:  John D Salamone; Merce Correa; Andrew M Farrar; Eric J Nunes; Marta Pardo
Journal:  Front Behav Neurosci       Date:  2009-09-07       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.